Humayun的研究小组即将对改良“仿生眼”进行新一轮的试验，他们将把改良后的“仿生眼”用于50到75名因色素性视网膜炎而失明的年过半百的人身上。
Humayun's team is about to embark on a new trial of an improved device, which they will fit into 50 to 75 people aged over 50, who are also blind as a result of retinitis pigmentosa.
Humayun的研究小组即将对改良“仿生眼”进行新一轮的试验，他们将把改良后的“仿生眼”用于50到75名因色素性视网膜炎而失明的年过半百的人身上。
Humayun's team is about to embark on a new trial of an improved device, which they will fit into 50 to 75 people aged over 50, who are also blind as a result of retinitis pigmentosa.
应用推荐